Tolerability of sublingual versus vestibular allergy immunotherapy tablet administration: A randomized pilot study.

Saved in:
Bibliographic Details
Title: Tolerability of sublingual versus vestibular allergy immunotherapy tablet administration: A randomized pilot study.
Authors: Simard ML; Clinique Spécialisée en Allergie de la Capitale, Québec, Québec, Canada., Novak N; Clinic and Polyclinic for Dermatology and Allergology, University Hospital Bonn, Bonn, Germany., Drolet JP; Clinique Spécialisée en Allergie de la Capitale, Québec, Québec, Canada., Joly MC; Clinique Spécialisée en Allergie de la Capitale, Québec, Québec, Canada., Nolte H; ALK, Bedminster, New Jersey, USA., Wuestenberg E; ALK-Abelló A/S, Hørsholm, Denmark.; Department of Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine (and University Hospital) Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Gagnon R; Clinique Spécialisée en Allergie de la Capitale, Québec, Québec, Canada.
Source: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2024 Feb; Vol. 54 (2), pp. 120-129. Date of Electronic Publication: 2023 Nov 21.
Publication Type: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 8906443 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2222 (Electronic) Linking ISSN: 09547894 NLM ISO Abbreviation: Clin Exp Allergy Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1365-2222
DOI:10.1111/cea.14427